Target
Ubiquitin carboxyl-terminal hydrolase isozyme L1
Ligand
BDBM445140
Substrate
n/a
Meas. Tech.
UCHL1 Biochemical IC50 Assay
IC50
550±n/a nM
Citation
 Kemp, MStockley, MJones, A Cyanopyrrolidines as dub inhibitors for the treatment of cancer US Patent  US10669234 Publication Date 6/2/2020 
Target
Name:
Ubiquitin carboxyl-terminal hydrolase isozyme L1
Synonyms:
Neuron cytoplasmic protein 9.5 | PGP 9.5 | PGP9.5 | UCH-L1 | UCHL1 | UCHL1_HUMAN | Ubiquitin thioesterase L1
Type:
PROTEIN
Mol. Mass.:
24819.03
Organism:
Homo sapiens (Human)
Description:
ChEMBL_974327
Residue:
223
Sequence:
MQLKPMEINPEMLNKVLSRLGVAGQWRFVDVLGLEEESLGSVPAPACALLLLFPLTAQHENFRKKQIEELKGQEVSPKVYFMKQTIGNSCGTIGLIHAVANNQDKLGFEDGSVLKQFLSETEKMSPEDRAKCFEKNEAIQAAHDAVAQEGQCRVDDKVNFHFILFNNVDGHLYELDGRMPFPVNHGASSEDTLLKDAAKVCREFTEREQGEVRFSAVALCKAA
  
Inhibitor
Name:
BDBM445140
Synonyms:
(S)-1-cyano-N-(4- (6-methoxypyridin- 2-yl)thiazol-2-yl)- N-methylpyrrolidine- 2-carboxamide | US10669234, Example 81 | US11319287, Example 81
Type:
Small organic molecule
Emp. Form.:
C16H17N5O2S
Mol. Mass.:
343.403
SMILES:
COc1cccc(n1)-c1csc(n1)N(C)C(=O)[C@@H]1CCCN1C#N
Structure:
Search PDB for entries with ligand similarity: